You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The approach deconvolutes admixed individuals' ancestries and develops polygenic risk scores based on each component that can then be combined.
News items for the week of March 30, 2020.
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
The firm believes that its molecular assay for the laboratory will help ease some of the supply chain issues hampering test rollout during the pandemic.
The test, developed by the firms in six weeks, is part of a viral respiratory panel and runs on Bosch's point-of-care Vivalytic system.
The researchers identified rare germline loss-of-function variants across the ELP1 gene in 14 percent of pediatric patients in a medulloblastoma subgroup.
Credo Diagnostics recently received the CE mark for the coronavirus test, which can provide results in 20 minutes.
An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.
The company is also participating in a study, being conducted at Hannover Medical School, investigating the genetics of susceptibility to COVID-19.
Protein profiling on ancient dental enamel samples suggests Homo antecessor was part of a lineage that split from that leading to modern humans and Neanderthals.
Retraction Watch writes that a cancer researcher has had an eighth paper retracted.
Computational biologist James Taylor has died, according to Johns Hopkins University.
The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.
In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.